A detailed history of Sachetta, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Sachetta, LLC holds 286 shares of NVO stock, worth $24,987. This represents 0.01% of its overall portfolio holdings.

Number of Shares
286
Previous 286 -0.0%
Holding current value
$24,987
Previous $37 Million 7.86%
% of portfolio
0.01%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$122.71 - $146.91 $4,785 - $5,729
-39 Reduced 12.0%
286 $37 Million
Q4 2023

Feb 09, 2024

BUY
$87.78 - $105.45 $28,528 - $34,271
325 New
325 $33.6 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Sachetta, LLC Portfolio

Follow Sachetta, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sachetta, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sachetta, LLC with notifications on news.